Hans K Hasselbalch

Hans K Hasselbalch

Clinical Professor

Member of:

  • Internal Medicine: Haematology


Publication year:
All
71 - 80 out of 133Page size: 10
Sort by: Title
  1. Published

    Molecular profiling as a novel tool to predict response to interferon-α2 in MPNs: The proof of concept in early myelofibrosis

    Hasselbalch, Hans Carl, 2017, In: Cancer. 123, 14, p. 2600-2603

    Research output: Contribution to journal › Editorial › Research

  2. Published

    Molecular profiling of peripheral blood cells from patients with polycythemia vera and related neoplasms: Identification of deregulated genes of significance for inflammation and immune surveillance

    Skov, V., Thomassen, M., Kruse, T. A., Larsen, T. S., Riley, C. H., Jensen, M. S. K., Bjerrum, O. W. & Hasselbalch, Hans Carl, 1 Nov 2012, In: Leukemia Research. 36, 11, p. 1387-1392 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Myeloproliferative Neoplasms in Danish Twins

    Andersen, M. A., Bjerrum, O. W., Ranjan, A., Skov, V., Kruse, T. A., Thomassen, M., Skytthe, A., Hasselbalch, Hans Carl & Christensen, K., 2018, In: Acta Haematologica. 139, 3, p. 195-198 4 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Myeloproliferative blood cancers as a human neuroinflammation model for development of Alzheimer's disease: evidences and perspectives

    Hasselbalch, Hans Carl, Skov, V., Kjær, L., Sørensen, Torben Lykke, Ellervik, Christina & Wienecke, Troels, 2020, In: Journal of Neuroinflammation. 17, 13 p., 248.

    Research output: Contribution to journal › Review › Research › peer-review

  5. Published

    Neo-antigen specific memory T-cell responses in healthy individuals

    Holmström, M. O., Hasselbalch, Hans Carl & Andersen, Mads Hald, 2019, In: OncoImmunology. 8, 7, 2 p., 1599640.

    Research output: Contribution to journal › Letter › Research › peer-review

  6. Published

    Neutrophil-to-lymphocyte ratio and all-cause mortality with and without myeloproliferative neoplasms-a Danish longitudinal study

    Larsen, Morten Kranker, Skov, V., Kjær, L., Eickhardt-Dalbøge, C. S., Knudsen, T. A., Kristiansen, M. H., Sørensen, A. L., Wienecke, Troels, Andersen, M., Ottesen, J. T., Gudmand-Høyer, J., Snyder, J. A., Andersen, M. P., Torp-Pedersen, Christian, Poulsen, Henrik Enghusen, Stiehl, T., Hasselbalch, Hans Carl & Ellervik, Christina, 2024, In: Blood Cancer Journal. 14, 1, 12 p., 28.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    New Perspectives of Interferon-alpha2 and Inflammation in Treating Philadelphia-negative Chronic Myeloproliferative Neoplasms

    Hasselbalch, Hans Carl & Silver, R. T., 2021, In: HemaSphere. 5, 12, p. 1-7 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Non-invasive imaging of retinal blood flow in myeloproliferative neoplasms

    Willerslev, A., Hansen, M. M., Klefter, O. N., Bjerrum, O. W., Hasselbalch, Hans Carl, Clemmensen, S. N., Larsen, Michael & Munch, I. C., Mar 2017, In: Acta Ophthalmologica. 95, 2, p. 146–152

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Ocular Manifestations in Patients with Philadelphia-Negative Myeloproliferative Neoplasms

    Liisborg, C., Hasselbalch, Hans Carl & Sørensen, Torben Lykke, 2020, In: Cancers. 12, 3, 14 p., 573.

    Research output: Contribution to journal › Review › Research › peer-review

  10. Published

    Optimal therapy for polycythemia vera and essential thrombocythemia: Preferred use of interferon therapy based on phase 2 trials

    Silver, R. T. & Hasselbalch, Hans Carl, 2016, In: Hematology. 21, 7, p. 387-391 5 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1...4 5 6 7 8 9 10 11 ...14 Next

ID: 2849472